Policy / Pricing Eli Lilly issues data sharing ultimatum to 340B hospitals BioPharma DiveSelect hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said.Read full story pharminent June 2, 2026 (Last updated: June 3, 2026) BioPharma Dive Select hospitals have refused to share data to prove they re not double-dipping drug discounts, Lilly said. Read full story Post navigation Previous: Fulcrum exploring a potential sale after FDA sidelined its sickle cell drugNext: ASCO26: In vivo CAR-Ts in the spotlight Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
